Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma

Abstract Background Ferroptosis is a recently recognised new type of cell death which may be a potential target for cancer therapy. In the present study, we aimed to screen ferroptosis-related differentially expressed long non-coding RNAs as biomarkers to predict the outcome of kidney renal clear ce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiao-Liang Xing, Zhi-Yong Yao, Jialan Ou, Chaoqun Xing, Feng Li
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/5bde10f48a5b4a76ab2a50d84942b639
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5bde10f48a5b4a76ab2a50d84942b639
record_format dspace
spelling oai:doaj.org-article:5bde10f48a5b4a76ab2a50d84942b6392021-11-08T11:13:37ZDevelopment and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma10.1186/s12935-021-02284-11475-2867https://doaj.org/article/5bde10f48a5b4a76ab2a50d84942b6392021-11-01T00:00:00Zhttps://doi.org/10.1186/s12935-021-02284-1https://doaj.org/toc/1475-2867Abstract Background Ferroptosis is a recently recognised new type of cell death which may be a potential target for cancer therapy. In the present study, we aimed to screen ferroptosis-related differentially expressed long non-coding RNAs as biomarkers to predict the outcome of kidney renal clear cell carcinoma. Methods RNAseq count data and corresponding clinical information were obtained from the Cancer Genome Atlas database. Lists of ferroptosis-related genes and long non-coding RNAs were obtained from the FerrDb and GENCODE databases, respectively. The candidate prognostic signatures were screened by Cox regression analyses and least absolute shrinkage and selection operator analyses. Results Three ferroptosis-related long non-coding RNAs (DUXAP8, LINC02609, and LUCAT1) were significantly correlated with the overall survival of kidney renal clear cell carcinoma independently. Kidney renal clear cell carcinoma patients with high-risk values displayed worse OS. Meanwhile, the expression of these three ferroptosis-related long non-coding RNAs and their risk scores were significantly correlated with clinicopathological features. Principal component analyses showed that patients with kidney renal clear cell carcinoma have differential risk values were well distinguished by the three ferroptosis-related long non-coding RNAs. Conclusions The present study suggests that the risk assessment model constructed by these three ferroptosis-related long non-coding RNAs could accurately predict the outcome of kidney renal clear cell carcinoma. We also provide a novel perspective for cancer prognosis screening.Xiao-Liang XingZhi-Yong YaoJialan OuChaoqun XingFeng LiBMCarticleKIRCFerroptosislncRNAPrognosis signaturesNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282CytologyQH573-671ENCancer Cell International, Vol 21, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic KIRC
Ferroptosis
lncRNA
Prognosis signatures
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671
spellingShingle KIRC
Ferroptosis
lncRNA
Prognosis signatures
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671
Xiao-Liang Xing
Zhi-Yong Yao
Jialan Ou
Chaoqun Xing
Feng Li
Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
description Abstract Background Ferroptosis is a recently recognised new type of cell death which may be a potential target for cancer therapy. In the present study, we aimed to screen ferroptosis-related differentially expressed long non-coding RNAs as biomarkers to predict the outcome of kidney renal clear cell carcinoma. Methods RNAseq count data and corresponding clinical information were obtained from the Cancer Genome Atlas database. Lists of ferroptosis-related genes and long non-coding RNAs were obtained from the FerrDb and GENCODE databases, respectively. The candidate prognostic signatures were screened by Cox regression analyses and least absolute shrinkage and selection operator analyses. Results Three ferroptosis-related long non-coding RNAs (DUXAP8, LINC02609, and LUCAT1) were significantly correlated with the overall survival of kidney renal clear cell carcinoma independently. Kidney renal clear cell carcinoma patients with high-risk values displayed worse OS. Meanwhile, the expression of these three ferroptosis-related long non-coding RNAs and their risk scores were significantly correlated with clinicopathological features. Principal component analyses showed that patients with kidney renal clear cell carcinoma have differential risk values were well distinguished by the three ferroptosis-related long non-coding RNAs. Conclusions The present study suggests that the risk assessment model constructed by these three ferroptosis-related long non-coding RNAs could accurately predict the outcome of kidney renal clear cell carcinoma. We also provide a novel perspective for cancer prognosis screening.
format article
author Xiao-Liang Xing
Zhi-Yong Yao
Jialan Ou
Chaoqun Xing
Feng Li
author_facet Xiao-Liang Xing
Zhi-Yong Yao
Jialan Ou
Chaoqun Xing
Feng Li
author_sort Xiao-Liang Xing
title Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
title_short Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
title_full Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
title_fullStr Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
title_full_unstemmed Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
title_sort development and validation of ferroptosis-related lncrnas prognosis signatures in kidney renal clear cell carcinoma
publisher BMC
publishDate 2021
url https://doaj.org/article/5bde10f48a5b4a76ab2a50d84942b639
work_keys_str_mv AT xiaoliangxing developmentandvalidationofferroptosisrelatedlncrnasprognosissignaturesinkidneyrenalclearcellcarcinoma
AT zhiyongyao developmentandvalidationofferroptosisrelatedlncrnasprognosissignaturesinkidneyrenalclearcellcarcinoma
AT jialanou developmentandvalidationofferroptosisrelatedlncrnasprognosissignaturesinkidneyrenalclearcellcarcinoma
AT chaoqunxing developmentandvalidationofferroptosisrelatedlncrnasprognosissignaturesinkidneyrenalclearcellcarcinoma
AT fengli developmentandvalidationofferroptosisrelatedlncrnasprognosissignaturesinkidneyrenalclearcellcarcinoma
_version_ 1718442334168809472